{"schema_version":"1","generated_at":"2026-11-20T14:45:58.533Z","data_as_of":null,"url":"https://www.findmykol.com/kol/amy-warriner","json_url":"https://www.findmykol.com/kol/amy-warriner/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"amy-warriner","name":"Amy Warriner","specialty":"Endocrinology, Diabetes & Metabolism","specialty_raw":"Endocrinology, Diabetes & Metabolism","therapeutic_area":"Endocrinology/Metabolic","therapeutic_areas":["Endocrinology/Metabolic"],"institution":"University of Alabama at Birmingham","institution_url":"https://www.findmykol.com/institution/university-of-alabama-at-birmingham","city":"Birmingham","state":"AL","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"}},"identifiers":{"on_file":["npi","openalex"],"values":"Shown on the profile page to a signed-in account."},"summary":"Amy Warriner is an Endocrinology/Metabolic physician affiliated with University of Alabama at Birmingham. OpenAlex indexes 51 publications with 1,409 citations (h-index 19); ClinicalTrials.gov lists 2 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Endocrinology/Metabolic"]},"scholarship":{"works_count":51,"cited_by_count":1409,"h_index":19,"latest_activity_year":2025,"source":"works"},"trials":{"count":2,"shown":3,"withheld":1,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT01591252","title":"Fracture and Bone Mineral Density in HIV+ Patients Recently Started on Antiretroviral Therapy (ART)","status":"COMPLETED","role":"Overall official","sponsor":"University of Alabama at Birmingham","source_url":"https://clinicaltrials.gov/study/NCT01591252","trial_url":"https://www.findmykol.com/trial/NCT01591252"},{"nct":"NCT01381926","title":"Changes in Bone Turnover With Exposure to a GLP-1 Receptor Agonist","phase":"PHASE4","status":"TERMINATED","role":"Overall official","sponsor":"University of Alabama at Birmingham","source_url":"https://clinicaltrials.gov/study/NCT01381926","trial_url":"https://www.findmykol.com/trial/NCT01381926"},{"nct":"NCT01378494","title":"Bone Mineral Density in HIV+ Patients","status":"COMPLETED","role":"Overall official","sponsor":"University of Alabama at Birmingham","source_url":"https://clinicaltrials.gov/study/NCT01378494","trial_url":"https://www.findmykol.com/trial/NCT01378494"}],"source":"trials"},"payments":{"company_count":4,"program_years":{"first":2021,"last":null},"rows_total":14,"shown":3,"withheld":11,"rows":[{"payer":"AbbVie","program_year":2025,"amount_usd":23771.8,"payment_count":6},{"payer":"Takeda","program_year":2025,"amount_usd":530,"payment_count":2},{"payer":"Neurocrine BioSciences, Inc.","program_year":2025,"amount_usd":24.04,"payment_count":1}],"source":"payments"},"prescribing":{"data_year":2023,"areas_total":6,"areas_shown":3,"areas":[{"area":"Metabolism & gastrointestinal","share_pct":47.6,"classes_total":6,"classes":[{"class":"GLP-1 receptor agonist","setting":"prescribed","share_pct":21.3,"drugs":[{"name":"Mounjaro","share_pct":41.2},{"name":"Trulicity","share_pct":38.7},{"name":"Ozempic","share_pct":20.1}],"max_beneficiaries":28},{"class":"Insulin Analog","setting":"prescribed","share_pct":9.6,"drugs":[{"name":"Tresiba Flextouch U-100","share_pct":30.7},{"name":"Lantus Solostar","share_pct":25.1},{"name":"Novolog Flexpen","share_pct":22.3},{"name":"Toujeo Solostar","share_pct":13.4},{"name":"Humalog Kwikpen U-100","share_pct":8.4}],"max_beneficiaries":null}]},{"area":"Hormonal (systemic)","share_pct":24.6,"classes_total":4,"classes":[{"class":"Parathyroid Hormone Analog","setting":"prescribed","share_pct":10.5,"drugs":[{"name":"Forteo","share_pct":100}],"max_beneficiaries":30},{"class":"l-Thyroxine","setting":"prescribed","share_pct":10.1,"drugs":[{"name":"Levothyroxine Sodium","share_pct":86.8},{"name":"Synthroid","share_pct":13.2}],"max_beneficiaries":null}]},{"area":"Musculoskeletal","share_pct":13,"classes_total":5,"classes":[{"class":"Bisphosphonate","setting":"prescribed","share_pct":5.4,"drugs":[{"name":"Zoledronic Acid","share_pct":100}],"max_beneficiaries":101},{"class":"Bisphosphonates","setting":"prescribed","share_pct":3.8,"drugs":[{"name":"Risedronate Sodium","share_pct":100}],"max_beneficiaries":17}]}],"care_setting":{"dominant":"facility","data_year":2023,"office_pct":17.1,"facility_pct":82.9},"source":"medicare"},"similar":[{"name":"Suzanne Oparil","slug":"suzanne-oparil","institution":"University of Alabama at Birmingham","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/suzanne-oparil","json_url":"https://www.findmykol.com/kol/suzanne-oparil/profile.json"},{"name":"Richard Whitley","slug":"richard-whitley","institution":"University of Alabama at Birmingham","specialty":"Pediatric Infectious Diseases","url":"https://www.findmykol.com/kol/richard-whitley","json_url":"https://www.findmykol.com/kol/richard-whitley/profile.json"},{"name":"David Standaert","slug":"david-standaert","institution":"University of Alabama at Birmingham","specialty":"Neurology","url":"https://www.findmykol.com/kol/david-standaert","json_url":"https://www.findmykol.com/kol/david-standaert/profile.json"},{"name":"John Hauth","slug":"john-hauth","institution":"University of Alabama at Birmingham","specialty":"Maternal & Fetal Medicine","url":"https://www.findmykol.com/kol/john-hauth","json_url":"https://www.findmykol.com/kol/john-hauth/profile.json"},{"name":"Yousef Saleh Khader","slug":"yousef-khader","institution":"Jordan University of Science and Technology","url":"https://www.findmykol.com/kol/yousef-khader","json_url":"https://www.findmykol.com/kol/yousef-khader/profile.json"},{"name":"Jens Juul Holst","slug":"jens-holst","institution":"University of Copenhagen","url":"https://www.findmykol.com/kol/jens-holst","json_url":"https://www.findmykol.com/kol/jens-holst/profile.json"},{"name":"Victor Montori","slug":"victor-montori","institution":"Mayo Clinic","specialty":"Endocrinology, Diabetes & Metabolism","url":"https://www.findmykol.com/kol/victor-montori","json_url":"https://www.findmykol.com/kol/victor-montori/profile.json"},{"name":"Christos Mantzoros","slug":"christos-mantzoros","institution":"Harvard Medical School","specialty":"Endocrinology, Diabetes & Metabolism","url":"https://www.findmykol.com/kol/christos-mantzoros","json_url":"https://www.findmykol.com/kol/christos-mantzoros/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":1,"payments":11}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2023}},"methodology_url":"https://www.findmykol.com/about#methodology"}